More information and required registration are available here. Dr. Melissa Moore, chief scientific officer at Moderna Therapeutics, will be hosted for a virtual seminar on February 10, 2021, 4:00– 5:00pm EST by the University of Michigan Center for RNA Biomedicine as part of the worldwide RNA Collaborative Seminar Series. The title of her talk is:…
BY PAUL AVEDISIAN and MICHELE SANTILLAN A team of U-M researchers has been awarded a $500,000 grant by the Cystic Fibrosis Foundation (CFF). Alexandra Piotrowski-Daspit, Ph.D., the PI, is a faculty member at the Center for RNA Biomedicine, and Assistant Professor of Biomedical Engineering and Internal Medicine – Pulmonary and Critical Care Medicine Division. Lindsay…
by Elisabeth Paymal Often overlooked because they might not alter the amino acid production, splicing defects can play an important role in rare genetic pituitary gland diseases. Several clinical endocrinologists and bioinformaticians, led by Sally Camper and Jacob Kitzman, Professors of Human Genetics at the University of Michigan Medical School (UMMS), came together to further…
Over 1,450 people attended our webinar with Melissa Moore, Chief Scientific Officer at Moderna Therapeutics, on March 3rd, 2021. In her presentation, Dr. Moore explained how the mRNA vaccine works, and how it was developed in record time of just 45 days. To put an end to this pandemic, she strongly encouraged the audience to…
Chase Weidmann had three goals for a career: do something “cool,” improve the lives of other people, and, of course, be able to support himself. Weidmann found the “cool” in high school science classes and he quickly realized that biology and `biotechnology offer vast uncharted territories to explore. One such uncharted area was the academic…
RNA Innovation Seminars (6/8/17): Palmer Commons, Fourth Floor Forum Hall –Max Wicha, MD “Regulation of breast cancer stem cells by non-coding RNA’s” (Abstract, Flyer) 5/18/17 RNA Seminar Grill and Dahl Thurs, May 18, 2017: Michigan League – Michigan Room (2nd Floor) –Sheri A. Grill “The long and short of human TPP1” and Jan Dahl “The anti-inflammatory drug mesalamine targets bacteria polyphosphate accumulation” (Grill Abstract, Dahl Abstract, Seminar Flyer) Thurs,…
